GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang AngliKang Pharmaceutical Co Ltd (SZSE:002940) » Definitions » Cyclically Adjusted Price-to-FCF

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Cyclically Adjusted Price-to-FCF : 26.51 (As of Jun. 06, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Zhejiang AngliKang Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-06), Zhejiang AngliKang Pharmaceutical Co's current share price is ¥19.62. Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec24 was ¥0.74. Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 26.51.

The historical rank and industry rank for Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:002940' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 17.43   Med: 19.15   Max: 31.5
Current: 20.47

During the past 11 years, Zhejiang AngliKang Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 31.50. The lowest was 17.43. And the median was 19.15.

SZSE:002940's Cyclically Adjusted Price-to-FCF is ranked better than
66.87% of 326 companies
in the Drug Manufacturers industry
Industry Median: 31.405 vs SZSE:002940: 20.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zhejiang AngliKang Pharmaceutical Co's adjusted free cash flow per share data of for the fiscal year that ended in Dec24 was ¥0.792. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.74 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang AngliKang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang AngliKang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Zhejiang AngliKang Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 33.02 17.92

Zhejiang AngliKang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 17.92 -

Competitive Comparison of Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Zhejiang AngliKang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=19.62/0.74
=26.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Zhejiang AngliKang Pharmaceutical Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec24 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=0.792/114.8925*114.8925
=0.792

Current CPI (Dec24) = 114.8925.

Zhejiang AngliKang Pharmaceutical Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.730 100.600 0.834
201612 0.819 102.600 0.917
201712 1.003 104.500 1.103
201812 0.438 106.500 0.473
201912 0.730 111.200 0.754
202012 0.566 111.500 0.583
202112 0.552 113.108 0.561
202212 0.583 115.116 0.582
202312 0.758 114.781 0.759
202412 0.792 114.893 0.792

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang AngliKang Pharmaceutical Co  (SZSE:002940) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Zhejiang AngliKang Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Zhejiang AngliKang Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang AngliKang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1000, North Luzhou Avenue, Zhejiang Province, Quzhou, CHN, 312400
Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The main products offered by the group are cephalosporins antibacterial, angiocarpy drugs and gastrointestinal tract drugs. Geographically, the activities are carried out through Shengzhou, China.
Executives
Pan Xiao Yun Supervisors
Ye Shu Xiang Director
Yang Guo Dong Executives
Xu Ai Fang Supervisors
Wu Zhe Hua Director

Zhejiang AngliKang Pharmaceutical Co Headlines

No Headlines